Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05063786
Title Trial of Trastuzumab + ALpelisib +/- Fulvestrant vs Trastuzumab + Chemotherapy in Patients With PIK3CA Mutated Previously Treated HER2+ Advanced BrEasT Cancer (ALPHABET)
Recruitment Recruiting
Gender both
Phase Phase III
Variant Requirements Yes
Sponsors Spanish Breast Cancer Research Group
Indications

Her2-receptor positive breast cancer

Therapies

Alpelisib + Fulvestrant + Trastuzumab

Trastuzumab + Vinorelbine

Alpelisib + Trastuzumab

Capecitabine + Trastuzumab

Eribulin + Trastuzumab

Age Groups: adult | senior
Covered Countries ESP

Additional content available in CKB BOOST